Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
| Status: | Recruiting |
|---|---|
| Conditions: | Lung Cancer, Pulmonary, Pulmonary |
| Therapuetic Areas: | Oncology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/14/2018 |
| Start Date: | August 1, 2018 |
| End Date: | January 2028 |
| Contact: | Tami Krpata |
| Email: | krpata.tami@mayo.edu |
| Phone: | 507-538-1979 |
To develop a repository of blood samples from patients with ILD to support future studies
into the development of such biomarkers. Patients with pneumonia and healthy patients will
also be recruited as a control group.
into the development of such biomarkers. Patients with pneumonia and healthy patients will
also be recruited as a control group.
The proposed biospecimen repository would be derived from patients diagnosed with ILD. This
is to include 500 patients in the repository, with each patient contributing one blood
sample. Patients with pneumonia and healthy patients will also be recruited as a control
group.
is to include 500 patients in the repository, with each patient contributing one blood
sample. Patients with pneumonia and healthy patients will also be recruited as a control
group.
Inclusion Criteria:
- Patients with a diagnosis of ILD or any fibrotic disease of the lung or a diagnosis of
pneumonia
- Patients willing to provide written informed consent
Exclusion Criteria:
- Unwillingness/unable to give blood samples
We found this trial at
1
site
Rochester, Minnesota 55905
Principal Investigator: Eva Carmona, M.D., Ph.D.
Phone: 507-284-9946
Click here to add this to my saved trials
